Oral Fosamprenavir + Sodium Alginate for GERD

Clinical trial NCT06704100 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06704100
Sponsor: Medical College of Wisconsin
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Gastroesophageal Reflux Disease Gastroesophageal Reflux Disease

Start date: 2027-01-01
Primary completion: 2028-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.